Most American hospital patients are given drugs not approved by the U.S. Food and Drug Administration for the prescribed use. If off-label prescribing is so widespread and successful, is the FDA’s pre-approval process really necessary?

Alexander T. Tabarrok is Senior Fellow at the Independent Institute, Assistant Editor of The Independent Review, and Associate Professor of Economics at George Mason University.
FDA and Drug RegulationHealth and Healthcare
Other Independent Review articles by Alexander T. Tabarrok
Fall 2019 Premature Imitation and India’s Flailing State
Fall 2013 The Global Organ Shortage: Economic Causes, Human Consequences, Policy Responses
Spring 2007 The Rise, Fall, and Rise Again of Privateers
[View All (4)]